4. Summary of outcomes by trials ‐ primary prevention.
Outcome | Death | Death (CV causes) | Non‐fatal MI | Stroke | Angina | Venous thromboembolism | Pulmonary embolism | Revascularisation |
Trial | ||||||||
DOPS 2012 | ✓ | ✓ | ✓ | ✓ | X | ✓ | X | X |
EPAT 2001 | X | X | ✓ | X | X | X | X | ✓ |
EPHT 2006 | ✓ | X | X1 | X | X | X | X | X |
ERT II 1979 | ✓ | X | ✓ | X | X | X | X | X |
Greenspan 2005 | ✓ | X | ✓ | X | X | ✓ | X | X |
STOP IT 2001 | ✓ | X | ✓ | ✓ | X | ✓ | X | X |
WHI I 2002 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
WHI II 2004 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
WISDOM 2007 | ✓ | X | X | X | X | ✓ | ✓ | X |
Number of trials | 8 | 3 | 7 | 4 | 2 | 6 | 3 | 3 |
Total N | 34,422 | 28,353 | 29,482 | 28,719 | 27,347 | 33,477 | 31,732 | 27,569 |
1 No events in control group. CV: cardiovascular; MI: myocardial infarction